Persistence of oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study

Persistence of oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study

Abstract Background In contrast to vitamin K antagonists (VKA), direct oral anticoagulants (DOAC's) are not strictly monitored and dose titrated by anticoagulation clinics in the Netherlands. This may affect drug persistence of atrial fibrillation (AF) patients, whom often require lifelong trea...

Full description

Bibliographic Details
Main Authors: Gilda Denise Zielinski, Nienke vanRein, Martina Teichert, Frederikus A. Klok, Frits R. Rosendaal, Felix J. M. van derMeer, Menno V. Huisman, Suzanne C. Cannegieter, Willem M. Lijfering
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Research and Practice in Thrombosis and Haemostasis
Subjects:
atrial fibrillation
direct oral anticoagulants
oral anticoagulants
Persistence
vitamin K antagonist
Online Access:https://doi.org/10.1002/rth2.12261

Internet

https://doi.org/10.1002/rth2.12261

Similar Items